Philip Morris fights to acquire a medical inhaler company
Read the transcript of this episode on FT.com
The pace of rising consumer prices in the United States in recent months will stagnate near a 13-year high in July, and SoftBank will cut its investment in Chinese start-ups until Beijing’s scrutiny of the technology industry becomes clear. In addition, private capital reporter Kaye Wiggins of the Financial Times provided the latest news on the battle between private equity group Carlyle and tobacco company Philip Morris International for the British medical inhaler manufacturer Vectura.
U.S. consumer price increases are expected to slow
Carlyle withdraws from bidding war between Vectura and Philip Morris
SoftBank will cut its investment in China until the technology industry calms down
The elusive Olympic rebound gives hope to Suga’s leading competitor
The FT news briefing was produced by Fiona Symon and Marc Filippino. The editor of the show is Jess Smith. Our intern is Zoe Han. Additional help from Gavin Kallmann, Michael Bruning and Persis Love. The theme song of the show is metaphorical music. The head of global audio for the Financial Times is Cheryl Brumley.
Look acast.com/privacy Privacy and opt-out information.
Transcripts for this podcast are currently unavailable. View our accessibility guide.